AU
UK
CA
US
IND
NZ
Company Overview
Yuanbao Inc. (YB), a leading technology-driven online insurance distributor in China, specializes in the seamless integration of insurance with advanced technologies, operating a highly efficient full consumer service cycle engine that has distributed tailored, high-quality insurance products to over ten million consumers, making it the largest independent distributor in China’s personal life and accident & health (A&H) insurance market by first-year premiums in 2023, according to Frost & Sullivan. The Company’s scalable engine, supported by approximately 4,700 models as of December 31, 2024, leverages predictive capabilities and interconnected networks to provide personalized services across recommendation, purchasing, policy management, claims, and post-sales, optimizing outcomes across diverse media channels, consumer preferences, and product offerings. Yuanbao collaborates robustly with insurance carriers, enabling them to develop flagship products that attract and retain a vast consumer base, while utilizing big data to deepen insights into consumer behavior, thereby enhancing both consumer satisfaction and carrier sales.
Initial Public Offering
The company launched its IPO on April 30th, 2025, under the ticker YB and had sold approximately 2,000,000 ADSs at USD 14.00 share. We had covered this IPO in our ‘Kalkine IPO Report’ on April 29, 2025, and had concluded that this IPO was “Attractive” given it given the financial performance of the company, use of proceeds, and associated risks.
Conclusion
The current price of $20.99 (October 9, 2025) offers a 49.93% gain from the IPO price of $14.00 price. However, the outlook carries increasing risk. Despite strong Q2 2025’s revenue, total operating expenses surged 16% year-over-year, driven by a 55.4% jump in R&D. This escalating cost base is putting pressure on near-term margins. Given the achieved return and the rising cost challenges, investors may consider exiting YB at $20.99 as on October 09, 2025, at 08:10 am PDT.
*The reference data in this report has been partly sourced from Refinitiv.
Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.
Past performance is not a reliable indicator of future performance.
Please wait processing your request...